NVIDIA Corporation vs UiPath, Inc. — Stock Comparison
Q·Score Breakdown
9.1
Very Bullish
Overall
7.8
Bullish
Quality
Health
Growth
Valuation
Sentiment
NVDA
Clean balance sheet with low leverage (0.1× debt-to-equity).
PATH
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ cautious analyst consensus — few Buy ratings.
Analyst Consensus
BUY
Target $269.17 (+35.6%)
57 analysts
HOLD
Target $13.80 (+29.4%)
16 analysts
Fundamentals
NVDA
PATH
40.5×
Trailing P/E
20.5×
17.7×
Forward P/E
11.9×
55.6%
Profit Margin
17.5%
71.1%
Gross Margin
83.2%
101.5%
ROE
14.4%
73.2%
Revenue Growth
13.6%
95.6%
Earnings Growth
105.7%
2.33
Beta
1.02
—
Price / Book
—
$4.82T
Market Cap
$5.6B
$111 – $217
52-Week Range
$9 – $20
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →